submitter_follow_up_id,program_id,submitter_donor_id,submitter_primary_diagnosis_id,submitter_treatment_id,date_of_followup,disease_status_at_followup,relapse_type,date_of_relapse,method_of_progression_status,anatomic_site_progression_or_recurrence
FOLLOW_UP_0001,SYNTH_01,DONOR_0001,DIAG_0001,,"{'day_interval': 2186, 'month_interval': 71}",No evidence of disease,Local recurrence,,Histopathology test (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0002,SYNTH_01,DONOR_0002,,TREATMENT_0003,,No evidence of disease,Local recurrence,,Assessment of symptom control (procedure)|Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0003,SYNTH_01,DONOR_0003,,,"{'day_interval': 3308, 'month_interval': 108}",Loco-regional progression,Local recurrence,"{'day_interval': 2063, 'month_interval': 67}",Histopathology test (procedure)|Assessment of symptom control (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0004,SYNTH_01,DONOR_0004,DIAG_0004,,"{'day_interval': 3142, 'month_interval': 103}",Stable,Biochemical progression,,Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0005,SYNTH_01,DONOR_0005,,TREATMENT_0009,"{'day_interval': 621, 'month_interval': 20}",Progression not otherwise specified,Local recurrence and distant metastasis,"{'day_interval': 244, 'month_interval': 8}",Histopathology test (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0006,SYNTH_01,DONOR_0006,,,"{'day_interval': 678, 'month_interval': 22}",,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0007,SYNTH_01,DONOR_0007,DIAG_0007,,"{'day_interval': 1833, 'month_interval': 60}",Partial remission,Local recurrence,,Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_0008,SYNTH_01,DONOR_0008,,TREATMENT_0015,,,Biochemical progression,,Assessment of symptom control (procedure)|Imaging (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0009,SYNTH_01,DONOR_0009,,,"{'day_interval': 2736, 'month_interval': 89}",Loco-regional progression,Distant recurrence/metastasis,"{'day_interval': 995, 'month_interval': 32}",Physical examination procedure (procedure)|Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0010,SYNTH_01,DONOR_0010,DIAG_0010,,"{'day_interval': 6446, 'month_interval': 211}",,Local recurrence and distant metastasis,,Histopathology test (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Imaging (procedure),
FOLLOW_UP_0011,SYNTH_01,DONOR_0011,,TREATMENT_0021,,Relapse or recurrence,Biochemical progression,,Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0012,SYNTH_01,DONOR_0012,,,"{'day_interval': 1646, 'month_interval': 54}",Relapse or recurrence,Local recurrence and distant metastasis,,Physical examination procedure (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0013,SYNTH_01,DONOR_0013,DIAG_0013,,"{'day_interval': 3087, 'month_interval': 101}",Loco-regional progression,Distant recurrence/metastasis,,Imaging (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0014,SYNTH_01,DONOR_0014,,TREATMENT_0027,"{'day_interval': 573, 'month_interval': 18}",No evidence of disease,Distant recurrence/metastasis,,Imaging (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure),
FOLLOW_UP_0015,SYNTH_01,DONOR_0015,,,"{'day_interval': 1897, 'month_interval': 62}",Distant progression,Local recurrence,"{'day_interval': 501, 'month_interval': 16}",Laboratory data interpretation (procedure)|Physical examination procedure (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0016,SYNTH_01,DONOR_0016,DIAG_0016,,"{'day_interval': 2971, 'month_interval': 97}",Loco-regional progression,Local recurrence and distant metastasis,"{'day_interval': 2286, 'month_interval': 75}",Laboratory data interpretation (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0017,SYNTH_01,DONOR_0017,,TREATMENT_0033,,,Local recurrence,,Histopathology test (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0018,SYNTH_01,DONOR_0018,,,"{'day_interval': 1113, 'month_interval': 36}",Distant progression,Progression (liquid tumours),"{'day_interval': 878, 'month_interval': 28}",Tumor marker measurement (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0019,SYNTH_01,DONOR_0019,DIAG_0019,,"{'day_interval': 6008, 'month_interval': 197}",,Local recurrence,,Imaging (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0020,SYNTH_01,DONOR_0020,,TREATMENT_0039,"{'day_interval': 668, 'month_interval': 21}",Distant progression,Distant recurrence/metastasis,"{'day_interval': 306, 'month_interval': 10}",Assessment of symptom control (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0021,SYNTH_01,DONOR_0021,,,"{'day_interval': 1363, 'month_interval': 44}",,Local recurrence,,Imaging (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0022,SYNTH_01,DONOR_0022,DIAG_0022,,"{'day_interval': 2630, 'month_interval': 86}",Loco-regional progression,Distant recurrence/metastasis,"{'day_interval': 1232, 'month_interval': 40}",Histopathology test (procedure)|Imaging (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0023,SYNTH_01,DONOR_0023,,TREATMENT_0045,,No evidence of disease,Local recurrence,,Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_0024,SYNTH_01,DONOR_0024,,,"{'day_interval': 6549, 'month_interval': 215}",Complete remission,Biochemical progression,,Histopathology test (procedure)|Assessment of symptom control (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0025,SYNTH_01,DONOR_0025,DIAG_0025,,"{'day_interval': 1500, 'month_interval': 49}",Distant progression,Distant recurrence/metastasis,"{'day_interval': 492, 'month_interval': 16}",Laboratory data interpretation (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0026,SYNTH_01,DONOR_0026,,TREATMENT_0051,"{'day_interval': 1008, 'month_interval': 33}",Progression not otherwise specified,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure),
FOLLOW_UP_0027,SYNTH_01,DONOR_0027,,,"{'day_interval': 1017, 'month_interval': 33}",Distant progression,Biochemical progression,"{'day_interval': 575, 'month_interval': 18}",Tumor marker measurement (procedure)|Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0028,SYNTH_01,DONOR_0028,DIAG_0028,,"{'day_interval': 540, 'month_interval': 17}",Partial remission,Biochemical progression,,Imaging (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0029,SYNTH_01,DONOR_0029,,TREATMENT_0057,"{'day_interval': 788, 'month_interval': 25}",Progression not otherwise specified,Biochemical progression,"{'day_interval': 647, 'month_interval': 21}",Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure),
FOLLOW_UP_0030,SYNTH_01,DONOR_0030,,,"{'day_interval': 11604, 'month_interval': 381}",Progression not otherwise specified,Biochemical progression,"{'day_interval': 1344, 'month_interval': 44}",Laboratory data interpretation (procedure)|Assessment of symptom control (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0031,SYNTH_01,DONOR_0031,DIAG_0031,,"{'day_interval': 4686, 'month_interval': 153}",No evidence of disease,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0032,SYNTH_01,DONOR_0032,,TREATMENT_0063,"{'day_interval': 1030, 'month_interval': 33}",Loco-regional progression,Distant recurrence/metastasis,"{'day_interval': 153, 'month_interval': 5}",Assessment of symptom control (procedure)|Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0033,SYNTH_01,DONOR_0033,,,,,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure)|Imaging (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0034,SYNTH_01,DONOR_0034,DIAG_0034,,"{'day_interval': 982, 'month_interval': 32}",Partial remission,Biochemical progression,,Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0035,SYNTH_01,DONOR_0035,,TREATMENT_0069,"{'day_interval': 821, 'month_interval': 26}",Relapse or recurrence,Local recurrence and distant metastasis,,Histopathology test (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0036,SYNTH_01,DONOR_0036,,,"{'day_interval': 1957, 'month_interval': 64}",Stable,Progression (liquid tumours),,Imaging (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0037,SYNTH_01,DONOR_0037,DIAG_0037,,"{'day_interval': 1574, 'month_interval': 51}",,Local recurrence,,Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Imaging (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0038,SYNTH_01,DONOR_0038,,TREATMENT_0075,"{'day_interval': 923, 'month_interval': 30}",,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0039,SYNTH_01,DONOR_0039,,,"{'day_interval': 10079, 'month_interval': 331}",Complete remission,Biochemical progression,,Imaging (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0040,SYNTH_01,DONOR_0040,DIAG_0040,,"{'day_interval': 992, 'month_interval': 32}",Distant progression,Local recurrence,"{'day_interval': 223, 'month_interval': 7}",Imaging (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure),
FOLLOW_UP_0041,SYNTH_01,DONOR_0041,,TREATMENT_0081,"{'day_interval': 674, 'month_interval': 22}",Relapse or recurrence,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0042,SYNTH_01,DONOR_0042,,,"{'day_interval': 4599, 'month_interval': 151}",Distant progression,Local recurrence and distant metastasis,,Imaging (procedure)|Laboratory data interpretation (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0043,SYNTH_01,DONOR_0043,DIAG_0043,,"{'day_interval': 6834, 'month_interval': 224}",Complete remission,Progression (liquid tumours),,Histopathology test (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0044,SYNTH_01,DONOR_0044,,TREATMENT_0087,"{'day_interval': 961, 'month_interval': 31}",Relapse or recurrence,Progression (liquid tumours),,Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0045,SYNTH_01,DONOR_0045,,,"{'day_interval': 3954, 'month_interval': 129}",No evidence of disease,Progression (liquid tumours),,Histopathology test (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0046,SYNTH_01,DONOR_0046,DIAG_0046,,"{'day_interval': 11729, 'month_interval': 385}",Relapse or recurrence,Distant recurrence/metastasis,,Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_0047,SYNTH_01,DONOR_0047,,TREATMENT_0093,"{'day_interval': 1060, 'month_interval': 34}",Stable,Local recurrence and distant metastasis,,Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0048,SYNTH_01,DONOR_0048,,,"{'day_interval': 1580, 'month_interval': 51}",Relapse or recurrence,Distant recurrence/metastasis,,Imaging (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure),
FOLLOW_UP_0049,SYNTH_01,DONOR_0049,DIAG_0049,,"{'day_interval': 5969, 'month_interval': 196}",No evidence of disease,Distant recurrence/metastasis,,Assessment of symptom control (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0050,SYNTH_01,DONOR_0050,,TREATMENT_0099,,,Biochemical progression,,Assessment of symptom control (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0051,SYNTH_02,DONOR_0201,,,,,Biochemical progression,,Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0052,SYNTH_02,DONOR_0202,DIAG_0202,,"{'day_interval': 4292, 'month_interval': 141}",Progression not otherwise specified,Local recurrence,,Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0053,SYNTH_02,DONOR_0203,,TREATMENT_0405,"{'day_interval': 627, 'month_interval': 20}",Distant progression,Local recurrence and distant metastasis,"{'day_interval': 494, 'month_interval': 16}",Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Imaging (procedure),
FOLLOW_UP_0054,SYNTH_02,DONOR_0204,,,"{'day_interval': 1931, 'month_interval': 63}",,Progression (liquid tumours),,Assessment of symptom control (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0055,SYNTH_02,DONOR_0205,DIAG_0205,,"{'day_interval': 1198, 'month_interval': 39}",Progression not otherwise specified,Progression (liquid tumours),"{'day_interval': 954, 'month_interval': 31}",Histopathology test (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0056,SYNTH_02,DONOR_0206,,TREATMENT_0411,,Stable,Local recurrence and distant metastasis,,Physical examination procedure (procedure)|Imaging (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0057,SYNTH_02,DONOR_0207,,,"{'day_interval': 4362, 'month_interval': 143}",,Local recurrence,,Physical examination procedure (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0058,SYNTH_02,DONOR_0208,DIAG_0208,,,Loco-regional progression,Biochemical progression,"{'day_interval': 212, 'month_interval': 6}",Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0059,SYNTH_02,DONOR_0209,,TREATMENT_0417,,Stable,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0060,SYNTH_02,DONOR_0210,,,"{'day_interval': 2847, 'month_interval': 93}",No evidence of disease,Biochemical progression,,Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0061,SYNTH_02,DONOR_0211,DIAG_0211,,,Partial remission,Local recurrence,,Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0062,SYNTH_02,DONOR_0212,,TREATMENT_0423,"{'day_interval': 787, 'month_interval': 25}",Distant progression,Progression (liquid tumours),,Histopathology test (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0063,SYNTH_02,DONOR_0213,,,"{'day_interval': 1231, 'month_interval': 40}",Relapse or recurrence,Progression (liquid tumours),,Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0064,SYNTH_02,DONOR_0214,DIAG_0214,,"{'day_interval': 3783, 'month_interval': 124}",No evidence of disease,Progression (liquid tumours),,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0065,SYNTH_02,DONOR_0215,,TREATMENT_0429,"{'day_interval': 651, 'month_interval': 21}",No evidence of disease,Progression (liquid tumours),,Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0066,SYNTH_02,DONOR_0216,,,,Relapse or recurrence,Biochemical progression,,Histopathology test (procedure)|Physical examination procedure (procedure)|Imaging (procedure),
FOLLOW_UP_0067,SYNTH_02,DONOR_0217,DIAG_0217,,"{'day_interval': 1428, 'month_interval': 46}",Progression not otherwise specified,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0068,SYNTH_02,DONOR_0218,,TREATMENT_0435,"{'day_interval': 491, 'month_interval': 16}",Partial remission,Local recurrence and distant metastasis,,Histopathology test (procedure)|Physical examination procedure (procedure)|Imaging (procedure),
FOLLOW_UP_0069,SYNTH_02,DONOR_0219,,,"{'day_interval': 3045, 'month_interval': 100}",,Local recurrence,,Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0070,SYNTH_02,DONOR_0220,DIAG_0220,,"{'day_interval': 519, 'month_interval': 17}",Relapse or recurrence,Local recurrence and distant metastasis,,Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0071,SYNTH_02,DONOR_0221,,TREATMENT_0441,"{'day_interval': 989, 'month_interval': 32}",Distant progression,Local recurrence and distant metastasis,"{'day_interval': 886, 'month_interval': 29}",Laboratory data interpretation (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0072,SYNTH_02,DONOR_0222,,,"{'day_interval': 7845, 'month_interval': 257}",,Local recurrence,,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0073,SYNTH_02,DONOR_0223,DIAG_0223,,"{'day_interval': 1199, 'month_interval': 39}",,Local recurrence,,Histopathology test (procedure)|Imaging (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0074,SYNTH_02,DONOR_0224,,TREATMENT_0447,"{'day_interval': 639, 'month_interval': 20}",Distant progression,Biochemical progression,"{'day_interval': 269, 'month_interval': 8}",Imaging (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0075,SYNTH_02,DONOR_0225,,,"{'day_interval': 697, 'month_interval': 22}",,Progression (liquid tumours),,Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0076,SYNTH_02,DONOR_0226,DIAG_0226,,"{'day_interval': 2756, 'month_interval': 90}",No evidence of disease,Biochemical progression,,Histopathology test (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0077,SYNTH_02,DONOR_0227,,TREATMENT_0453,"{'day_interval': 684, 'month_interval': 22}",Loco-regional progression,Biochemical progression,"{'day_interval': 672, 'month_interval': 22}",Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0078,SYNTH_02,DONOR_0228,,,"{'day_interval': 3364, 'month_interval': 110}",,Biochemical progression,,Imaging (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0079,SYNTH_02,DONOR_0229,DIAG_0229,,"{'day_interval': 11078, 'month_interval': 363}",Complete remission,Progression (liquid tumours),,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Imaging (procedure),
FOLLOW_UP_0080,SYNTH_02,DONOR_0230,,TREATMENT_0459,"{'day_interval': 824, 'month_interval': 27}",,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0081,SYNTH_02,DONOR_0231,,,,Complete remission,Local recurrence and distant metastasis,,Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Imaging (procedure),
FOLLOW_UP_0082,SYNTH_02,DONOR_0232,DIAG_0232,,"{'day_interval': 4503, 'month_interval': 147}",Progression not otherwise specified,Biochemical progression,"{'day_interval': 641, 'month_interval': 21}",Imaging (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0083,SYNTH_02,DONOR_0233,,TREATMENT_0465,"{'day_interval': 761, 'month_interval': 25}",Progression not otherwise specified,Local recurrence and distant metastasis,"{'day_interval': 238, 'month_interval': 7}",Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0084,SYNTH_02,DONOR_0234,,,"{'day_interval': 15095, 'month_interval': 495}",Distant progression,Biochemical progression,"{'day_interval': 4566, 'month_interval': 150}",Physical examination procedure (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0085,SYNTH_02,DONOR_0235,DIAG_0235,,"{'day_interval': 3115, 'month_interval': 102}",,Biochemical progression,,Histopathology test (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0086,SYNTH_02,DONOR_0236,,TREATMENT_0471,"{'day_interval': 480, 'month_interval': 15}",,Local recurrence and distant metastasis,,Laboratory data interpretation (procedure)|Assessment of symptom control (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0087,SYNTH_02,DONOR_0237,,,"{'day_interval': 6886, 'month_interval': 226}",Relapse or recurrence,Distant recurrence/metastasis,,Imaging (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0088,SYNTH_02,DONOR_0238,DIAG_0238,,"{'day_interval': 1162, 'month_interval': 38}",Distant progression,Local recurrence,"{'day_interval': 592, 'month_interval': 19}",Laboratory data interpretation (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0089,SYNTH_02,DONOR_0239,,TREATMENT_0477,,,Distant recurrence/metastasis,,Histopathology test (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0090,SYNTH_02,DONOR_0240,,,"{'day_interval': 1799, 'month_interval': 59}",Relapse or recurrence,Progression (liquid tumours),,Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Imaging (procedure),
FOLLOW_UP_0091,SYNTH_02,DONOR_0241,DIAG_0241,,"{'day_interval': 3211, 'month_interval': 105}",Complete remission,Progression (liquid tumours),,Tumor marker measurement (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0092,SYNTH_02,DONOR_0242,,TREATMENT_0483,"{'day_interval': 936, 'month_interval': 30}",Progression not otherwise specified,Progression (liquid tumours),"{'day_interval': 741, 'month_interval': 24}",Imaging (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0093,SYNTH_02,DONOR_0243,,,,Stable,Local recurrence,,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0094,SYNTH_02,DONOR_0244,DIAG_0244,,"{'day_interval': 550, 'month_interval': 18}",Stable,Local recurrence and distant metastasis,,Physical examination procedure (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0095,SYNTH_02,DONOR_0245,,TREATMENT_0489,"{'day_interval': 834, 'month_interval': 27}",Complete remission,Distant recurrence/metastasis,,Imaging (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0096,SYNTH_02,DONOR_0246,,,"{'day_interval': 828, 'month_interval': 27}",Progression not otherwise specified,Distant recurrence/metastasis,"{'day_interval': 341, 'month_interval': 11}",Histopathology test (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0097,SYNTH_02,DONOR_0247,DIAG_0247,,"{'day_interval': 2291, 'month_interval': 75}",,Progression (liquid tumours),,Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0098,SYNTH_02,DONOR_0248,,TREATMENT_0495,,Relapse or recurrence,Progression (liquid tumours),,Imaging (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0099,SYNTH_02,DONOR_0249,,,"{'day_interval': 7796, 'month_interval': 256}",No evidence of disease,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0100,SYNTH_02,DONOR_0250,DIAG_0250,,,Partial remission,Biochemical progression,,Imaging (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0101,SYNTH_03,DONOR_0401,,TREATMENT_0801,"{'day_interval': 544, 'month_interval': 17}",,Biochemical progression,,Histopathology test (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0102,SYNTH_03,DONOR_0402,,,,Progression not otherwise specified,Biochemical progression,"{'day_interval': 118, 'month_interval': 3}",Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0103,SYNTH_03,DONOR_0403,DIAG_0403,,"{'day_interval': 1386, 'month_interval': 45}",Distant progression,Progression (liquid tumours),"{'day_interval': 646, 'month_interval': 21}",Histopathology test (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0104,SYNTH_03,DONOR_0404,,TREATMENT_0807,"{'day_interval': 584, 'month_interval': 19}",Stable,Local recurrence and distant metastasis,,Imaging (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0105,SYNTH_03,DONOR_0405,,,"{'day_interval': 10005, 'month_interval': 328}",Stable,Local recurrence,,Histopathology test (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0106,SYNTH_03,DONOR_0406,DIAG_0406,,"{'day_interval': 1356, 'month_interval': 44}",Distant progression,Local recurrence and distant metastasis,"{'day_interval': 1038, 'month_interval': 34}",Laboratory data interpretation (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0107,SYNTH_03,DONOR_0407,,TREATMENT_0813,"{'day_interval': 953, 'month_interval': 31}",Progression not otherwise specified,Local recurrence,"{'day_interval': 210, 'month_interval': 6}",Tumor marker measurement (procedure)|Histopathology test (procedure)|Imaging (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0108,SYNTH_03,DONOR_0408,,,"{'day_interval': 2598, 'month_interval': 85}",Stable,Biochemical progression,,Tumor marker measurement (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0109,SYNTH_03,DONOR_0409,DIAG_0409,,"{'day_interval': 1929, 'month_interval': 63}",Stable,Biochemical progression,,Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0110,SYNTH_03,DONOR_0410,,TREATMENT_0819,"{'day_interval': 977, 'month_interval': 32}",,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0111,SYNTH_03,DONOR_0411,,,"{'day_interval': 10802, 'month_interval': 354}",Stable,Local recurrence,,Imaging (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0112,SYNTH_03,DONOR_0412,DIAG_0412,,"{'day_interval': 11061, 'month_interval': 363}",Partial remission,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0113,SYNTH_03,DONOR_0413,,TREATMENT_0825,"{'day_interval': 968, 'month_interval': 31}",Loco-regional progression,Distant recurrence/metastasis,"{'day_interval': 812, 'month_interval': 26}",Assessment of symptom control (procedure)|Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0114,SYNTH_03,DONOR_0414,,,"{'day_interval': 9159, 'month_interval': 300}",,Distant recurrence/metastasis,,Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0115,SYNTH_03,DONOR_0415,DIAG_0415,,"{'day_interval': 2873, 'month_interval': 94}",Complete remission,Distant recurrence/metastasis,,Imaging (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0116,SYNTH_03,DONOR_0416,,TREATMENT_0831,"{'day_interval': 564, 'month_interval': 18}",,Local recurrence,,Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0117,SYNTH_03,DONOR_0417,,,"{'day_interval': 3722, 'month_interval': 122}",,Local recurrence,,Physical examination procedure (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0118,SYNTH_03,DONOR_0418,DIAG_0418,,"{'day_interval': 6580, 'month_interval': 216}",Stable,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_0119,SYNTH_03,DONOR_0419,,TREATMENT_0837,"{'day_interval': 997, 'month_interval': 32}",Partial remission,Biochemical progression,,Imaging (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure),
FOLLOW_UP_0120,SYNTH_03,DONOR_0420,,,"{'day_interval': 4377, 'month_interval': 143}",Loco-regional progression,Progression (liquid tumours),"{'day_interval': 2763, 'month_interval': 90}",Histopathology test (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0121,SYNTH_03,DONOR_0421,DIAG_0421,,"{'day_interval': 2969, 'month_interval': 97}",Distant progression,Biochemical progression,"{'day_interval': 1428, 'month_interval': 46}",Tumor marker measurement (procedure)|Imaging (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0122,SYNTH_03,DONOR_0422,,TREATMENT_0843,,No evidence of disease,Biochemical progression,,Histopathology test (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0123,SYNTH_03,DONOR_0423,,,"{'day_interval': 3159, 'month_interval': 103}",No evidence of disease,Local recurrence,,Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0124,SYNTH_03,DONOR_0424,DIAG_0424,,"{'day_interval': 2488, 'month_interval': 81}",Complete remission,Distant recurrence/metastasis,,Imaging (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0125,SYNTH_03,DONOR_0425,,TREATMENT_0849,"{'day_interval': 714, 'month_interval': 23}",Stable,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0126,SYNTH_03,DONOR_0426,,,"{'day_interval': 5551, 'month_interval': 182}",Distant progression,Biochemical progression,"{'day_interval': 1252, 'month_interval': 41}",Laboratory data interpretation (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0127,SYNTH_03,DONOR_0427,DIAG_0427,,"{'day_interval': 7904, 'month_interval': 259}",Progression not otherwise specified,Local recurrence,"{'day_interval': 4759, 'month_interval': 156}",Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0128,SYNTH_03,DONOR_0428,,TREATMENT_0855,"{'day_interval': 1110, 'month_interval': 36}",,Local recurrence,,Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0129,SYNTH_03,DONOR_0429,,,"{'day_interval': 4464, 'month_interval': 146}",Loco-regional progression,Local recurrence,,Histopathology test (procedure)|Assessment of symptom control (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0130,SYNTH_03,DONOR_0430,DIAG_0430,,,Loco-regional progression,Biochemical progression,"{'day_interval': 345, 'month_interval': 11}",Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0131,SYNTH_03,DONOR_0431,,TREATMENT_0861,"{'day_interval': 1043, 'month_interval': 34}",No evidence of disease,Local recurrence,,Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0132,SYNTH_03,DONOR_0432,,,"{'day_interval': 1312, 'month_interval': 43}",Partial remission,Biochemical progression,,Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0133,SYNTH_03,DONOR_0433,DIAG_0433,,"{'day_interval': 2632, 'month_interval': 86}",Complete remission,Progression (liquid tumours),,Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0134,SYNTH_03,DONOR_0434,,TREATMENT_0867,"{'day_interval': 976, 'month_interval': 32}",Stable,Local recurrence and distant metastasis,,Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Imaging (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0135,SYNTH_03,DONOR_0435,,,"{'day_interval': 1994, 'month_interval': 65}",Complete remission,Local recurrence,,Imaging (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0136,SYNTH_03,DONOR_0436,DIAG_0436,,"{'day_interval': 2154, 'month_interval': 70}",Progression not otherwise specified,Biochemical progression,"{'day_interval': 573, 'month_interval': 18}",Imaging (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0137,SYNTH_03,DONOR_0437,,TREATMENT_0873,,Loco-regional progression,Distant recurrence/metastasis,"{'day_interval': 25, 'month_interval': 0}",Histopathology test (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0138,SYNTH_03,DONOR_0438,,,"{'day_interval': 2339, 'month_interval': 76}",Stable,Local recurrence,,Histopathology test (procedure)|Laboratory data interpretation (procedure)|Assessment of symptom control (procedure)|Imaging (procedure),
FOLLOW_UP_0139,SYNTH_03,DONOR_0439,DIAG_0439,,"{'day_interval': 1810, 'month_interval': 59}",Relapse or recurrence,Local recurrence,,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0140,SYNTH_03,DONOR_0440,,TREATMENT_0879,"{'day_interval': 492, 'month_interval': 16}",Partial remission,Biochemical progression,,Tumor marker measurement (procedure)|Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0141,SYNTH_03,DONOR_0441,,,"{'day_interval': 444, 'month_interval': 14}",Progression not otherwise specified,Biochemical progression,"{'day_interval': 387, 'month_interval': 12}",Imaging (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0142,SYNTH_03,DONOR_0442,DIAG_0442,,"{'day_interval': 959, 'month_interval': 31}",Progression not otherwise specified,Local recurrence and distant metastasis,"{'day_interval': 891, 'month_interval': 29}",Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0143,SYNTH_03,DONOR_0443,,TREATMENT_0885,,Relapse or recurrence,Local recurrence,,Tumor marker measurement (procedure)|Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0144,SYNTH_03,DONOR_0444,,,"{'day_interval': 14647, 'month_interval': 481}",Loco-regional progression,Local recurrence and distant metastasis,"{'day_interval': 11661, 'month_interval': 383}",Laboratory data interpretation (procedure)|Physical examination procedure (procedure)|Imaging (procedure),
FOLLOW_UP_0145,SYNTH_03,DONOR_0445,DIAG_0445,,"{'day_interval': 1563, 'month_interval': 51}",Loco-regional progression,Distant recurrence/metastasis,"{'day_interval': 1314, 'month_interval': 43}",Laboratory data interpretation (procedure)|Imaging (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0146,SYNTH_03,DONOR_0446,,TREATMENT_0891,"{'day_interval': 860, 'month_interval': 28}",,Local recurrence,,Imaging (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_0147,SYNTH_03,DONOR_0447,,,"{'day_interval': 3008, 'month_interval': 98}",Progression not otherwise specified,Biochemical progression,"{'day_interval': 931, 'month_interval': 30}",Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0148,SYNTH_03,DONOR_0448,DIAG_0448,,"{'day_interval': 2035, 'month_interval': 66}",Complete remission,Biochemical progression,,Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0149,SYNTH_03,DONOR_0449,,TREATMENT_0897,"{'day_interval': 716, 'month_interval': 23}",,Distant recurrence/metastasis,,Imaging (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0150,SYNTH_03,DONOR_0450,,,"{'day_interval': 3274, 'month_interval': 107}",Distant progression,Local recurrence,"{'day_interval': 1855, 'month_interval': 60}",Laboratory data interpretation (procedure)|Imaging (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0151,SYNTH_04,DONOR_0601,DIAG_0601,,"{'day_interval': 3112, 'month_interval': 102}",,Local recurrence and distant metastasis,,Imaging (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0152,SYNTH_04,DONOR_0602,,TREATMENT_1203,"{'day_interval': 630, 'month_interval': 20}",Stable,Local recurrence and distant metastasis,,Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0153,SYNTH_04,DONOR_0603,,,,Relapse or recurrence,Progression (liquid tumours),,Laboratory data interpretation (procedure)|Imaging (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0154,SYNTH_04,DONOR_0604,DIAG_0604,,"{'day_interval': 11113, 'month_interval': 365}",No evidence of disease,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0155,SYNTH_04,DONOR_0605,,TREATMENT_1209,,Complete remission,Local recurrence,,Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0156,SYNTH_04,DONOR_0606,,,"{'day_interval': 2082, 'month_interval': 68}",,Local recurrence and distant metastasis,,Physical examination procedure (procedure)|Imaging (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0157,SYNTH_04,DONOR_0607,DIAG_0607,,"{'day_interval': 3979, 'month_interval': 130}",Loco-regional progression,Progression (liquid tumours),"{'day_interval': 3214, 'month_interval': 105}",Tumor marker measurement (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0158,SYNTH_04,DONOR_0608,,TREATMENT_1215,"{'day_interval': 1161, 'month_interval': 38}",Relapse or recurrence,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure),
FOLLOW_UP_0159,SYNTH_04,DONOR_0609,,,"{'day_interval': 2046, 'month_interval': 67}",Distant progression,Distant recurrence/metastasis,,Physical examination procedure (procedure)|Imaging (procedure)|Assessment of symptom control (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0160,SYNTH_04,DONOR_0610,DIAG_0610,,"{'day_interval': 5929, 'month_interval': 194}",Loco-regional progression,Local recurrence,"{'day_interval': 5202, 'month_interval': 170}",Histopathology test (procedure)|Physical examination procedure (procedure)|Imaging (procedure),
FOLLOW_UP_0161,SYNTH_04,DONOR_0611,,TREATMENT_1221,,,Local recurrence and distant metastasis,,Imaging (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0162,SYNTH_04,DONOR_0612,,,"{'day_interval': 4620, 'month_interval': 151}",,Biochemical progression,,Physical examination procedure (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0163,SYNTH_04,DONOR_0613,DIAG_0613,,"{'day_interval': 941, 'month_interval': 30}",Relapse or recurrence,Distant recurrence/metastasis,,Imaging (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0164,SYNTH_04,DONOR_0614,,TREATMENT_1227,,Complete remission,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0165,SYNTH_04,DONOR_0615,,,"{'day_interval': 12956, 'month_interval': 425}",Relapse or recurrence,Biochemical progression,,Histopathology test (procedure)|Laboratory data interpretation (procedure)|Physical examination procedure (procedure)|Imaging (procedure),
FOLLOW_UP_0166,SYNTH_04,DONOR_0616,DIAG_0616,,"{'day_interval': 1792, 'month_interval': 58}",Distant progression,Local recurrence and distant metastasis,"{'day_interval': 38, 'month_interval': 1}",Imaging (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure),
FOLLOW_UP_0167,SYNTH_04,DONOR_0617,,TREATMENT_1233,"{'day_interval': 912, 'month_interval': 29}",Stable,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0168,SYNTH_04,DONOR_0618,,,"{'day_interval': 2254, 'month_interval': 74}",Distant progression,Local recurrence and distant metastasis,,Imaging (procedure)|Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0169,SYNTH_04,DONOR_0619,DIAG_0619,,"{'day_interval': 2002, 'month_interval': 65}",Partial remission,Biochemical progression,,Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure)|Assessment of symptom control (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0170,SYNTH_04,DONOR_0620,,TREATMENT_1239,"{'day_interval': 706, 'month_interval': 23}",Loco-regional progression,Progression (liquid tumours),"{'day_interval': 561, 'month_interval': 18}",Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0171,SYNTH_04,DONOR_0621,,,"{'day_interval': 840, 'month_interval': 27}",No evidence of disease,Progression (liquid tumours),,Imaging (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0172,SYNTH_04,DONOR_0622,DIAG_0622,,"{'day_interval': 1345, 'month_interval': 44}",Complete remission,Progression (liquid tumours),,Imaging (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0173,SYNTH_04,DONOR_0623,,TREATMENT_1245,"{'day_interval': 405, 'month_interval': 13}",Loco-regional progression,Progression (liquid tumours),"{'day_interval': 75, 'month_interval': 2}",Assessment of symptom control (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0174,SYNTH_04,DONOR_0624,,,"{'day_interval': 6892, 'month_interval': 226}",No evidence of disease,Biochemical progression,,Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0175,SYNTH_04,DONOR_0625,DIAG_0625,,"{'day_interval': 3461, 'month_interval': 113}",,Progression (liquid tumours),,Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_0176,SYNTH_04,DONOR_0626,,TREATMENT_1251,,Partial remission,Local recurrence,,Physical examination procedure (procedure)|Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0177,SYNTH_04,DONOR_0627,,,,Stable,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Imaging (procedure),
FOLLOW_UP_0178,SYNTH_04,DONOR_0628,DIAG_0628,,"{'day_interval': 9664, 'month_interval': 317}",No evidence of disease,Progression (liquid tumours),,Physical examination procedure (procedure)|Imaging (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0179,SYNTH_04,DONOR_0629,,TREATMENT_1257,"{'day_interval': 627, 'month_interval': 20}",Distant progression,Local recurrence,"{'day_interval': 580, 'month_interval': 19}",Imaging (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0180,SYNTH_04,DONOR_0630,,,"{'day_interval': 1458, 'month_interval': 47}",No evidence of disease,Local recurrence and distant metastasis,,Physical examination procedure (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0181,SYNTH_04,DONOR_0631,DIAG_0631,,"{'day_interval': 8037, 'month_interval': 264}",Stable,Local recurrence,,Histopathology test (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0182,SYNTH_04,DONOR_0632,,TREATMENT_1263,"{'day_interval': 572, 'month_interval': 18}",Progression not otherwise specified,Progression (liquid tumours),"{'day_interval': 189, 'month_interval': 6}",Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0183,SYNTH_04,DONOR_0633,,,"{'day_interval': 1673, 'month_interval': 54}",,Progression (liquid tumours),,Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure)|Imaging (procedure),
FOLLOW_UP_0184,SYNTH_04,DONOR_0634,DIAG_0634,,"{'day_interval': 1387, 'month_interval': 45}",,Distant recurrence/metastasis,,Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0185,SYNTH_04,DONOR_0635,,TREATMENT_1269,"{'day_interval': 566, 'month_interval': 18}",Partial remission,Progression (liquid tumours),,Histopathology test (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0186,SYNTH_04,DONOR_0636,,,"{'day_interval': 2937, 'month_interval': 96}",Progression not otherwise specified,Progression (liquid tumours),"{'day_interval': 1696, 'month_interval': 55}",Imaging (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0187,SYNTH_04,DONOR_0637,DIAG_0637,,"{'day_interval': 3162, 'month_interval': 103}",No evidence of disease,Distant recurrence/metastasis,,Histopathology test (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0188,SYNTH_04,DONOR_0638,,TREATMENT_1275,"{'day_interval': 629, 'month_interval': 20}",,Local recurrence,,Tumor marker measurement (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0189,SYNTH_04,DONOR_0639,,,"{'day_interval': 1026, 'month_interval': 33}",Progression not otherwise specified,Local recurrence and distant metastasis,,Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0190,SYNTH_04,DONOR_0640,DIAG_0640,,"{'day_interval': 2169, 'month_interval': 71}",Partial remission,Biochemical progression,,Imaging (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0191,SYNTH_04,DONOR_0641,,TREATMENT_1281,,Loco-regional progression,Biochemical progression,"{'day_interval': 17, 'month_interval': 0}",Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_0192,SYNTH_04,DONOR_0642,,,"{'day_interval': 4815, 'month_interval': 158}",Relapse or recurrence,Progression (liquid tumours),,Imaging (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0193,SYNTH_04,DONOR_0643,DIAG_0643,,"{'day_interval': 6210, 'month_interval': 204}",Loco-regional progression,Local recurrence,"{'day_interval': 1848, 'month_interval': 60}",Assessment of symptom control (procedure)|Imaging (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0194,SYNTH_04,DONOR_0644,,TREATMENT_1287,,Progression not otherwise specified,Local recurrence,"{'day_interval': 330, 'month_interval': 10}",Laboratory data interpretation (procedure)|Assessment of symptom control (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0195,SYNTH_04,DONOR_0645,,,"{'day_interval': 3143, 'month_interval': 103}",Stable,Local recurrence,,Imaging (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0196,SYNTH_04,DONOR_0646,DIAG_0646,,"{'day_interval': 793, 'month_interval': 26}",Stable,Biochemical progression,,Imaging (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0197,SYNTH_04,DONOR_0647,,TREATMENT_1293,"{'day_interval': 625, 'month_interval': 20}",Relapse or recurrence,Progression (liquid tumours),,Physical examination procedure (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0198,SYNTH_04,DONOR_0648,,,"{'day_interval': 2996, 'month_interval': 98}",,Progression (liquid tumours),,Histopathology test (procedure)|Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0199,SYNTH_04,DONOR_0649,DIAG_0649,,"{'day_interval': 9072, 'month_interval': 298}",Progression not otherwise specified,Progression (liquid tumours),"{'day_interval': 5343, 'month_interval': 175}",Assessment of symptom control (procedure)|Imaging (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0200,SYNTH_04,DONOR_0650,,TREATMENT_1299,,Partial remission,Biochemical progression,,Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_NULL_0001,SYNTH_01,DONOR_NULL_0001,,,"{'day_interval': 1681, 'month_interval': 55}",,,,,
FOLLOW_UP_NULL_0002,SYNTH_01,DONOR_NULL_0002,DIAG_NULL_0002,,"{'day_interval': 869, 'month_interval': 28}",,,,,
FOLLOW_UP_ALL_0001,SYNTH_01,DONOR_ALL_0001,,TREATMENT_ALL_0001,"{'day_interval': 996, 'month_interval': 32}",Partial remission,Local recurrence,,Physical examination procedure (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_ALL_0002,SYNTH_01,DONOR_ALL_0002,,,,Partial remission,Local recurrence and distant metastasis,,Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
